Question follow-through · 96493
Hospitals: Private Sector
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential impact of staff undertaking additional work in private hospitals on NHS workforce capacity.
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 2 Dec 2025
- Target answer date
- 4 Dec 2025
- Answer
- 8 Dec 2025 · 6 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
More questions by this MP on Health and care
- Skin Diseases: Steroid Drugs · 26 Jan 2026
- Skin Diseases: Steroid Drugs · 26 Jan 2026
- Skin Diseases: Steroid Drugs · 26 Jan 2026
- Skin Diseases: Steroid Drugs · 26 Jan 2026
- Skin Diseases: Steroid Drugs · 26 Jan 2026
Shared topic keywords suggest a connection; they do not establish a follow-up.
Votes on this topic
- Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
- Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
- Health Bill: Report Stage: New Clause 143 · 8 Sept 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
2 Dec 2025
Question tabled
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential impact of staff undertaking additional work in private hospitals on NHS workforce capacity.
4 Dec 2025
Target answer date
Date supplied by the official written-questions record.
8 Dec 2025
Answer published
The Department has made no assessment of the impact of National Health Service staff undertaking additional work in private hospitals on NHS workforce capacity.
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
Skin Diseases: Steroid Drugs
26 Jan 2026 · To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that Integrated Care Boards monitor implementation of MHRA safety alerts on Topical Steroid Withdrawal across GP practices and community pharmacies.
Skin Diseases: Steroid Drugs
26 Jan 2026 · To ask the Secretary of State for Health and Social Care, whether his Department plans to mandate (a) training and (b) continuing professional development for prescribers and pharmacists on recognising and managing Topical Steroid Withdrawal.
Skin Diseases: Steroid Drugs
26 Jan 2026 · To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the adequacy of Yellow Card reporting for capturing cases of Topical Steroid Withdrawal.
Skin Diseases: Steroid Drugs
26 Jan 2026 · To ask the Secretary of State for Health and Social Care, if he will publish guidance clarifying which organisation is responsible for ensuring that prescribers act on updated patient-safety information on topical corticosteroids.
Skin Diseases: Steroid Drugs
26 Jan 2026 · To ask the Secretary of State for Health and Social Care, whether the upcoming integration of NHS England into the Department will affect the operation of Directed Enhanced Services or Structured Medication Reviews in relation to long-term topical steroid
Prescriptions: Fees and Charges
24 Mar 2026 · To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the effectiveness of the NHS prescription exemption-checking system.
Steroid Drugs: Prescriptions
24 Mar 2026 · To ask the Secretary of State for Health and Social Care, which national body has responsibility for routinely auditing prescribing data to identify GP repeat-prescribing of topical corticosteroids that is (a) long-term and (b) high-potency.
Steroid Drugs: Prescriptions
24 Mar 2026 · To ask the Secretary of State for Health and Social Care, whether (a) NHS England and (b) his Department has considered introducing a national (i) prescribing indicator and (ii) thematic audit on (A) long-term and (B) high-potency topical corticosteroid u
Skin Diseases: Steroid Drugs
24 Mar 2026 · To ask the Secretary of State for Health and Social Care, what data (a) his Department and (b) NHS England holds on the proportion of prescribers and pharmacists who have received training on the risks of Topical Steroid Withdrawal.
Skin Diseases: Steroid Drugs
24 Mar 2026 · To ask the Secretary of State for Health and Social Care, what guidance has been issued to clinicians on recording suspected Topical Steroid Withdrawal in patient medical records, including GP records, where a formal diagnosis has not been made.
Skin Diseases: Steroid Drugs
24 Mar 2026 · To ask the Secretary of State for Health and Social Care, whether NHS England has assessed the potential merits of a dedicated referral and support pathway for patients experiencing Topical Steroid Withdrawal, distinct from standard eczema care.
Social Services: Staff
25 Mar 2026 · To ask the Secretary of State for Health and Social Care, what steps are being taken to prevent abuse of social care staff, including threatening unemployment, wage theft, and abuse of overtime.